Posaconazole Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Dec 2, 2025 · last update Dec 2, 2025
Manufacturers: Merck Sharp & Dohme Corp.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01) | Merck Sharp & Dohme Corp. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Dec 2, 2025 Updated Dec 2, 2025 Discontinued Dec 2, 2025 |